1. Home
  2. PCRX vs CGBD Comparison

PCRX vs CGBD Comparison

Compare PCRX & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.78

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$11.40

Market Cap

772.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
CGBD
Founded
2006
2012
Country
United States
United States
Employees
N/A
2500
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
772.5M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
CGBD
Price
$23.78
$11.40
Analyst Decision
Strong Buy
Hold
Analyst Count
4
8
Target Price
$30.25
$12.92
AVG Volume (30 Days)
518.7K
751.8K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
14.92%
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$3.74
Revenue Next Year
$8.54
$1.80
P/E Ratio
$150.19
$10.36
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$10.64
52 Week High
$27.99
$15.15

Technical Indicators

Market Signals
Indicator
PCRX
CGBD
Relative Strength Index (RSI) 57.59 56.56
Support Level $23.74 $10.64
Resistance Level $23.94 $11.44
Average True Range (ATR) 0.73 0.28
MACD 0.11 0.05
Stochastic Oscillator 75.36 94.72

Price Performance

Historical Comparison
PCRX
CGBD

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: